| Table 1. Cycle Characteristics. | |||||
| Characteristics median (IQR) |
All Patients n=63 |
AMH | p-value | ||
|---|---|---|---|---|---|
| <1 ng/mL n=6 |
1-3.5 ng/mL n=32 |
>3.5 ng/mL n=25 |
|||
| Age | 35.0 (33.0, 38.0) | 38.8 (35.0, 40.0) | 35.0 (33.0, 37.5) | 35.0 (32.0, 38.0) | 0.28 |
| BMI | 26.0 (23.2, 33.2) | 28.9 (26.8, 30.1) | 25.7 (22.8, 33.4) | 25.5 (23.6, 30.7) | 0.92 |
| Prior Spontaneous Abortions | 2.0 (2.0, 3.0) | 2.0 (2.0, 3.0) | 2.0 (2.0, 3.0) | 2.0 (2.0, 3.0) | 0.96 |
| Prior Therapeutic Abortions | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0.96 |
| Prior Ectopic Pregnancies | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | none |
| Prior Live Births | 0 (0, 1.0) | 0.5 (0, 1.0) | 0 (0, 1.0) | 0 (0, 1.0) | 0.90 |
| Number IVF Cycles Completed | 1.0 (1.0, 1.0) | 1.0 (1.0, 1.0) | 1.0 (1.0, 1.5) | 1.0 (1.0, 1.0) | 0.77 |
| Number IVF Cycles Canceled | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0.46 |
| Total Blastocysts |
8.0 (4.0, 10.0) | 4.0 (3.0, 5.0) | 7.0 (4.0, 10.0) | 9.0 (7.0, 13.0) | 0.02 |
| Euploid Blastocysts | 4.0 (2.0, 5.0) | 3.0 (1.0, 4.0) | 4.0 (3.0, 5.0) | 9.0 (7.0, 13.0) | 0.08 |
*After obtaining significant differences in the total number of blastocysts with the Kruskal-Wallis test, pairwise Wilcoxon rank-sum tests with Bonferroni correction were performed (significance level: 0.05/3 = 0.0167). A significant difference was observed between patients with AMH<1 ng/mL and AMH > 3.5 ng/mL (p=0.007). However, no significant differences were observed between patients with AMH<1 ng/mL and AMH 1-3.5 ng/mL (p=0.03) or between patients with AMH 1-3.5 ng/mL and AMH > 3.5 ng/mL (p=0.16).